Matthew L Kelso

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice
    Matthew L Kelso
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA
    BMC Neurosci 10:108. 2009
  2. ncbi The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice
    Matthew L Kelso
    College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA
    Brain Res 1083:204-10. 2006
  3. ncbi Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury
    Matthew L Kelso
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA
    Neurosci Lett 488:60-4. 2011
  4. ncbi Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury
    Matthew L Kelso
    Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Prog Mol Biol Transl Sci 98:85-131. 2011
  5. ncbi Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders
    Kimberly Nixon
    Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, 40536 0082, USA
    Alcohol 44:39-56. 2010

Detail Information

Publications5

  1. ncbi Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice
    Matthew L Kelso
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA
    BMC Neurosci 10:108. 2009
    ..The purpose of the current study was to determine the role of the COX isoforms in contributing to pathological processes resulting from TBI by utilizing mice deficient in COX-1 or COX-2...
  2. ncbi The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice
    Matthew L Kelso
    College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA
    Brain Res 1083:204-10. 2006
    ..However, when null mutant mice develop in the absence of central alpha7 expression, it is possible that compensatory changes occur that confound the results obtained...
  3. ncbi Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury
    Matthew L Kelso
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA
    Neurosci Lett 488:60-4. 2011
    ..These results suggest that neither drug has therapeutic efficacy, however dosing and/or administration issues may have played a role...
  4. ncbi Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury
    Matthew L Kelso
    Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Prog Mol Biol Transl Sci 98:85-131. 2011
    ..The purpose of this chapter is to highlight some of the promising molecular and cellular targets that have been identified and to provide an up-to-date summary of the development of therapeutic compounds for those targets...
  5. ncbi Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders
    Kimberly Nixon
    Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, 40536 0082, USA
    Alcohol 44:39-56. 2010
    ..However, many more studies are needed to discern whether these developmental differences contribute to the vulnerability of the adolescent to developing an AUD...